Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NPF-08
- Development stage
- Phase 2
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
NPF-08 is an investigational drug evaluated as a bowel preparation agent for patients undergoing colonoscopy. Clinical trials have compared NPF-08 to established bowel cleansing regimens such as Moviprep, using both 1-day and 2-day split dosing schedules. The precise active ingredients and mechanism of action for NPF-08 are not specified in the available sources, but it is used in the context of colonoscopy preparation, suggesting it functions as an osmotic or stimulant laxative to clear the bowel prior to endoscopic examination[4]. The developer or sponsor appears to be from industry, but no specific company name is provided.
Beyond the preview
Go deeper on NPF-08.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NPF-08.